Tag: VentureMed Group
VentureMed to present new data on DCB treatment for PAD
VentureMed Group has announced new data presentations on the treatment of peripheral arterial disease (PAD) with drug-coated balloon (DCBs) in addition to 12-month AV...
VentureMed completes enrolment of Flex Vessel Prep system randomised controlled trial...
VentureMed Group recently announced that it has completed enrolment of a randomised controlled trial (RCT) titled 'Flex Vessel Prep prior to PTA for the...
Three studies evaluating Flex Vessel Prep system presented during LINC 2021
VentureMed Group announced today that data from three studies evaluating the use of its Flex Vessel Prep (VP) system were presented during LINC 2021...
Flex vessel preparation system effectively limits potential complications in the femoral...
The Flex vessel preparation system (VentureMed group) is safe and effective, and appears to limit the potential risks of dissection and perforation of chronic...
FLEX vessel prep system data show key findings including luminal gain
New data presented at the 20th annual new cardiovascular horizons (NCVH) conference (29–31 May, New Orleans, USA) show positive results for VentureMed Group’s FLEX...
BELONG study enrols first patients
Enrolment of the first patients in the BELONG study—benefit of arterial vessel preparation by arterial by longitudinal micro-incisions before drug-eluting balloon angioplasty of the...
Second iDissection Classification study to evaluate dissection rate of FLEX Dynamic...
VentureMed Group has announced the initiation of a new study to determine if the FLEX Dynamic Scoring Catheter reduces dissections and the need for...
